{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:05:12Z","timestamp":1790046312978,"version":"4.0.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:00:00Z","timestamp":1607385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:00:00Z","timestamp":1607385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    COVID-19 patients show heterogeneity in clinical presentation and outcomes that makes pandemic control and strategy difficult; optimizing management requires a systems biology approach of understanding the disease. Here we sought to potentially understand and infer complex disease progression, immune regulation, and symptoms in patients infected with coronaviruses (35 SARS-CoV and 3 SARS-CoV-2 patients and 57 samples) at two different disease progression stages. Further, we compared coronavirus data with healthy individuals (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200916) and patients with other infections (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009144; all publicly available data). We applied inferential statistics (the COVID-engine platform) to RNA profiles (from limited number of samples) derived from peripheral blood mononuclear cells (PBMCs). Compared to healthy individuals, a subset of integrated blood-based gene profiles (signatures) distinguished acute-like (mimicking coronavirus-infected patients with prolonged hospitalization) from recovering-like patients. These signatures also hierarchically represented multiple (at the system level) parameters associated with PBMC including dysregulated cytokines, genes, pathways, networks of pathways\/concepts, immune status, and cell types. Proof-of-principle observations included PBMC-based increases in cytokine storm-associated\n                    <jats:italic>IL6<\/jats:italic>\n                    , enhanced innate immunity (macrophages and neutrophils), and lower adaptive T and B cell immunity in patients with acute-like disease compared to those with recovery-like disease. Patients in the recovery-like stage showed significantly enhanced\n                    <jats:italic>TNF<\/jats:italic>\n                    ,\n                    <jats:italic>IFN-\u03b3<\/jats:italic>\n                    , anti-viral,\n                    <jats:italic>HLA-DQA1<\/jats:italic>\n                    , and\n                    <jats:italic>HLA-F<\/jats:italic>\n                    gene expression and cytolytic activity, and reduced pro-viral gene expression compared to those in the acute-like stage in PBMC. Besides, our analysis revealed overlapping genes associated with potential comorbidities (associated diabetes) and disease-like conditions (associated with thromboembolism, pneumonia, lung disease, and septicemia). Overall, our COVID-engine inferential statistics platform and study involving PBMC-based RNA profiling may help understand complex and variable system-wide responses displayed by coronavirus-infected patients with further validation.\n                  <\/jats:p>","DOI":"10.1038\/s41420-020-00376-x","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T06:29:58Z","timestamp":1607408998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-5150","authenticated-orcid":false,"given":"Anguraj","family":"Sadanandam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Bopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J. H. F.","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra Priya","family":"Emperumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paschalis","family":"Vergidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4175-9633","authenticated-orcid":false,"given":"Krishnaraj","family":"Rajalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Melcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8825-2178","authenticated-orcid":false,"given":"Nagarajan","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,8]]},"reference":[{"key":"376_CR1","unstructured":"World Health Organization, Coronavirus disease 2019 (COVID-19) Weekly epidemiological update. (1 December 2020); https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update---1-december-2020."},{"key":"376_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2467","author":"JEL Wong","year":"2020","unstructured":"Wong, J. E. L., Leo, Y. S. & Tan, C. C. COVID-19 in Singapore\u2014current experience: critical global issues that require attention and action. JAMA https:\/\/doi.org\/10.1001\/jama.2020.2467 (2020).","journal-title":"JAMA"},{"key":"376_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/bs.aivir.2016.08.006","volume":"96","author":"E Kindler","year":"2016","unstructured":"Kindler, E., Thiel, V. & Weber, F. Interaction of SARS and MERS coronaviruses with the antiviral interferon response. Adv. Virus Res. 96, 219\u2013243 (2016).","journal-title":"Adv. Virus Res"},{"key":"376_CR4","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1002\/jcp.27155","volume":"234","author":"S Shokri","year":"2019","unstructured":"Shokri, S., Mahmoudvand, S., Taherkhani, R. & Farshadpour, F. Modulation of the immune response by Middle East respiratory syndrome coronavirus. J. Cell Physiol. 234, 2143\u20132151 (2019).","journal-title":"J. Cell Physiol."},{"key":"376_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000503030","volume":"12","author":"M Kikkert","year":"2020","unstructured":"Kikkert, M. Innate immune evasion by human respiratory RNA viruses. J. Innate Immun. 12, 4\u201320 (2020).","journal-title":"J. Innate Immun."},{"key":"376_CR6","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1001\/jama.2020.1960","volume":"323","author":"DL Swerdlow","year":"2020","unstructured":"Swerdlow, D. L. & Finelli, L. Preparation for possible sustained transmission of 2019 novel coronavirus: lessons from previous epidemics. JAMA 323, 1129\u20131130 (2020).","journal-title":"JAMA"},{"key":"376_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1126\/science.368.6489.356","volume":"368","author":"M Wadman","year":"2020","unstructured":"Wadman, M., Couzin-Frankel, J., Kaiser, J. & Matacic, C. How does coronavirus kill? Clinicians trace a ferocious rampage through the body, from brain to toes. Science 368, 356\u2013360 (2020).","journal-title":"Science"},{"key":"376_CR8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/jama.2020.1097","volume":"323","author":"AL Phelan","year":"2020","unstructured":"Phelan, A. L., Katz, R. & Gostin, L. O. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA 323, 709\u2013710 (2020).","journal-title":"JAMA"},{"key":"376_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ijid.2020.03.020","volume":"94","author":"H Nishiura","year":"2020","unstructured":"Nishiura, H. et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int. J. Infect. Dis. 94, 154\u2013155 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"376_CR10","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1056\/NEJMc2003100","volume":"382","author":"OT Ng","year":"2020","unstructured":"Ng, O. T. et al. SARS-CoV-2 infection among travelers returning from Wuhan, China. N. Engl. J. Med. 382, 1476\u20131478 (2020).","journal-title":"N. Engl. J. Med."},{"key":"376_CR11","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2020.2565","volume":"323","author":"Y Bai","year":"2020","unstructured":"Bai, Y. et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 323, 1406\u20131407 (2020).","journal-title":"JAMA"},{"key":"376_CR12","doi-asserted-by":"publisher","unstructured":"Wang, L., Gao, Y. H., Lou, L. L. & Zhang, G. J. The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China. Eur. Respir. J., https:\/\/doi.org\/10.1183\/13993003.00398-2020 (2020).","DOI":"10.1183\/13993003.00398-2020"},{"key":"376_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ijid.2020.03.003","volume":"93","author":"D Chen","year":"2020","unstructured":"Chen, D. et al. Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report. Int J. Infect. Dis. 93, 297\u2013299 (2020).","journal-title":"Int J. Infect. Dis."},{"key":"376_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/pathogens9020148","volume":"9","author":"B Shanmugaraj","year":"2020","unstructured":"Shanmugaraj, B., Malla, A. & Phoolcharoen, W. Emergence of novel coronavirus 2019-nCoV: need for rapid vaccine and biologics development. Pathogens 9, 148 (2020).","journal-title":"Pathogens"},{"key":"376_CR15","doi-asserted-by":"publisher","unstructured":"Pang, J. et al. Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review. J. Clin. Med. 9, https:\/\/doi.org\/10.3390\/jcm9030623 (2020).","DOI":"10.3390\/jcm9030623"},{"key":"376_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2172-6-2","volume":"6","author":"R Reghunathan","year":"2005","unstructured":"Reghunathan, R. et al. Expression profile of immune response genes in patients with severe acute respiratory syndrome. BMC Immunol. 6, 2 (2005).","journal-title":"BMC Immunol."},{"key":"376_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","volume":"9","author":"Y Xiong","year":"2020","unstructured":"Xiong, Y. et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerg. Microbes Infect. 9, 761\u2013770 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"376_CR18","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1182\/blood-2006-02-002477","volume":"109","author":"O Ramilo","year":"2007","unstructured":"Ramilo, O. et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109, 2066\u20132077 (2007).","journal-title":"Blood"},{"key":"376_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-6-132","volume":"6","author":"YS Lee","year":"2005","unstructured":"Lee, Y. S. et al. Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV). BMC Genomics 6, 132 (2005).","journal-title":"BMC Genomics"},{"key":"376_CR20","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"376_CR21","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1121","volume":"143","author":"J Pugin","year":"1991","unstructured":"Pugin, J. et al. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic \u201cblind\u201d bronchoalveolar lavage fluid. Am. Rev. Respir. Dis. 143, 1121\u20131129 (1991).","journal-title":"Am. Rev. Respir. Dis."},{"key":"376_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015543","volume":"5","author":"Y Hoshida","year":"2010","unstructured":"Hoshida, Y. Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment. PLoS ONE 5, e15543 (2010).","journal-title":"PLoS ONE"},{"key":"376_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/cei.12612","volume":"181","author":"M Rutkowska-Zapala","year":"2015","unstructured":"Rutkowska-Zapala, M. et al. Human monocyte subsets exhibit divergent angiotensin I-converting activity. Clin. Exp. Immunol. 181, 126\u2013132 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"376_CR24","doi-asserted-by":"publisher","unstructured":"Nikitina, E., Larionova, I., Choinzonov, E. & Kzhyshkowska, J. Monocytes and macrophages as viral targets and reservoirs. Int. J. Mol. Sci. 19, https:\/\/doi.org\/10.3390\/ijms19092821 (2018).","DOI":"10.3390\/ijms19092821"},{"key":"376_CR25","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","volume":"10","author":"EJ Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis, E. J. et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe 10, 992\u20131000 (2020).","journal-title":"Cell Host Microbe"},{"key":"376_CR26","doi-asserted-by":"publisher","unstructured":"Ottestad, W., Seim, M. & M\u00e6hlen, J. O. COVID-19 with silent hypoxemia. Tidsskr Nor Laegeforen 140, https:\/\/doi.org\/10.4045\/tidsskr.20.0299 (2020).","DOI":"10.4045\/tidsskr.20.0299"},{"key":"376_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.120.047430","volume":"142","author":"J Poissy","year":"2020","unstructured":"Poissy, J. et al. Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence. Circulation 142, 184\u2013186 (2020).","journal-title":"Circulation"},{"key":"376_CR28","first-page":"D498","volume":"48","author":"B Jassal","year":"2020","unstructured":"Jassal, B. et al. The reactome pathway knowledgebase. Nucleic Acids Res. 48, D498\u2013D503 (2020).","journal-title":"Nucleic Acids Res."},{"issue":"Suppl 1","key":"376_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1538-7836.2011.04323.x","volume":"9","author":"CT Esmon","year":"2011","unstructured":"Esmon, C. T., Xu, J. & Lupu, F. Innate immunity and coagulation. J. Thromb. Haemost. 9(Suppl 1), 182\u2013188 (2011).","journal-title":"J. Thromb. Haemost."},{"key":"376_CR30","doi-asserted-by":"publisher","unstructured":"Mathian, A. & Amoura, Z. Response to: \u2018Are patients with systemic lupus erythematosus at increased risk for COVID-19?\u2019 by Favalli et al. Ann. Rheum. Dis., https:\/\/doi.org\/10.1136\/annrheumdis-2020-217859 (2020).","DOI":"10.1136\/annrheumdis-2020-217859"},{"key":"376_CR31","doi-asserted-by":"publisher","unstructured":"Mathian, A. et al. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine. Ann. Rheum. Dis., https:\/\/doi.org\/10.1136\/annrheumdis-2020-217566 (2020).","DOI":"10.1136\/annrheumdis-2020-217566"},{"key":"376_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.virol.2015.02.017","volume":"479\u2013480","author":"AM Kell","year":"2015","unstructured":"Kell, A. M. & Gale, M. Jr. RIG-I in RNA virus recognition. Virology 479\u2013480, 110\u2013121 (2015).","journal-title":"Virology"},{"key":"376_CR33","doi-asserted-by":"publisher","first-page":"a004820","DOI":"10.1101\/cshperspect.a004820","volume":"3","author":"M Lorizate","year":"2011","unstructured":"Lorizate, M. & Krausslich, H. G. Role of lipids in virus replication. Cold Spring Harb. Perspect. Biol. 3, a004820 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"376_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","volume":"160","author":"MS Rooney","year":"2015","unstructured":"Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G. & Hacohen, N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160, 48\u201361 (2015).","journal-title":"Cell"},{"key":"376_CR35","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489\u20131501.e15 (2020).","journal-title":"Cell"},{"key":"376_CR36","doi-asserted-by":"publisher","first-page":"D313","DOI":"10.1093\/nar\/gkv1104","volume":"44","author":"C Wu","year":"2016","unstructured":"Wu, C., Jin, X., Tsueng, G., Afrasiabi, C. & Su, A. I. BioGPS: building your own mash-up of gene annotations and expression profiles. Nucleic Acids Res. 44, D313\u2013D316 (2016).","journal-title":"Nucleic Acids Res."},{"key":"376_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/d41586-020-01056-7","volume":"580","author":"H Ledford","year":"2020","unstructured":"Ledford, H. How does COVID-19 kill? Uncertainty is hampering doctors\u2019 ability to choose treatments. Nature 580, 311\u2013312 (2020).","journal-title":"Nature"},{"key":"376_CR38","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1056\/NEJMe2009758","volume":"382","author":"M Gandhi","year":"2020","unstructured":"Gandhi, M., Yokoe, D. S. & Havlir, D. V. Asymptomatic transmission, the Achilles\u2019 heel of current strategies to control Covid-19. N. Engl. J. Med. 382, 2158\u20132160 (2020).","journal-title":"N. Engl. J. Med"},{"key":"376_CR39","first-page":"e6","volume":"81","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J. Infect. 81, e6\u2013e12 (2020).","journal-title":"J. Infect."},{"key":"376_CR40","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1016\/S2352-3026(20)30109-5","volume":"7","author":"T Wang","year":"2020","unstructured":"Wang, T. et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. 7, e362\u2013e363 (2020).","journal-title":"Lancet Haematol."},{"key":"376_CR41","doi-asserted-by":"publisher","unstructured":"Jose, R. J. & Manuel, A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir. Med., https:\/\/doi.org\/10.1016\/S2213-2600(20)30216-2 (2020).","DOI":"10.1016\/S2213-2600(20)30216-2"},{"key":"376_CR42","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay, M. Z., Poh, C. M., Renia, L., MacAry, P. A. & Ng, L. F. P. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20, 363\u2013374 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"376_CR43","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/ni.3513","volume":"17","author":"WF Garcia-Beltran","year":"2016","unstructured":"Garcia-Beltran, W. F. et al. Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1. Nat. Immunol. 17, 1067\u20131074 (2016).","journal-title":"Nat. Immunol."},{"key":"376_CR44","doi-asserted-by":"crossref","unstructured":"Zhang, D. et al. COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes. J. Leukoc. Biol. (2020).","DOI":"10.1101\/2020.03.24.20042655"},{"key":"376_CR45","doi-asserted-by":"crossref","unstructured":"Zhou, Y. et al. Pathogenic T-cells and inflammatory monocytes incite inflammatory stormsin severe COVID-19 patients. Natl Sci. Rev. 7, 998\u20131002 (2020).","DOI":"10.1093\/nsr\/nwaa041"},{"key":"376_CR46","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","volume":"20","author":"X Cao","year":"2020","unstructured":"Cao, X. COVID-19: immunopathology and its implications for therapy. Nat. Rev. Immunol. 20, 269\u2013270 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"376_CR47","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1080\/21505594.2018.1426965","volume":"9","author":"D Parker","year":"2018","unstructured":"Parker, D. A live vaccine to Staphylococcus aureus infection. Virulence 9, 700\u2013702 (2018).","journal-title":"Virulence"},{"key":"376_CR48","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.bbmt.2020.04.008","volume":"26","author":"V Bachanova","year":"2020","unstructured":"Bachanova, V. et al. Chimeric antigen receptor T cell therapy during the COVID-19 pandemic. Biol. Blood Marrow Transpl. 26, 1239\u20131246 (2020).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"376_CR49","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier, L., Cope, L., Bolstad, B. M. & Irizarry, R. A. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307\u2013315 (2004).","journal-title":"Bioinformatics"},{"key":"376_CR50","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","volume":"23","author":"S Davis","year":"2007","unstructured":"Davis, S. & Meltzer, P. S. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics 23, 1846\u20131847 (2007).","journal-title":"Bioinformatics"},{"key":"376_CR51","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA 98, 5116\u20135121 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"376_CR52","unstructured":"Schwender, H. siggenes: Multiple Testing using SAM and Efron\u2019s Empirical Bayes Approaches. R package version 1.62.0 (R Foundation for Statistical Computing, 2020)."},{"key":"376_CR53","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson, E. A. et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 17, 500\u2013503 (2011).","journal-title":"Nat. Med."},{"key":"376_CR54","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nm.3175","volume":"19","author":"A Sadanandam","year":"2013","unstructured":"Sadanandam, A. et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat. Med. 19, 619\u2013625 (2013).","journal-title":"Nat. Med."},{"key":"376_CR55","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1158\/2159-8290.CD-15-0068","volume":"5","author":"A Sadanandam","year":"2015","unstructured":"Sadanandam, A. et al. A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics. Cancer Discov. 5, 1296\u20131313 (2015).","journal-title":"Cancer Discov."},{"key":"376_CR56","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ng0506-500","volume":"38","author":"M Reich","year":"2006","unstructured":"Reich, M. et al. GenePattern 2.0. Nat. Genet. 38, 500\u2013501 (2006).","journal-title":"Nat. Genet"},{"key":"376_CR57","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/bioinformatics\/btz700","volume":"36","author":"A Federico","year":"2020","unstructured":"Federico, A. & Monti, S. hypeR: an R package for geneset enrichment workflows. Bioinformatics 36, 1307\u20131308 (2020).","journal-title":"Bioinformatics"},{"key":"376_CR58","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/bioinformatics\/btu684","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu, G., Wang, L. G., Yan, G. R. & He, Q. Y. DOSE: an R\/Bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics 31, 608\u2013609 (2015).","journal-title":"Bioinformatics"},{"key":"376_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).","journal-title":"BMC Bioinformatics"},{"key":"376_CR60","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353\u2013D361 (2017).","journal-title":"Nucleic Acids Res."},{"key":"376_CR61","doi-asserted-by":"publisher","first-page":"bau012","DOI":"10.1093\/database\/bau012","volume":"2014","author":"JX Binder","year":"2014","unstructured":"Binder, J. X. et al. COMPARTMENTS: unification and visualization of protein subcellular localization evidence. Database (Oxf.) 2014, bau012 (2014).","journal-title":"Database (Oxf.)"},{"key":"376_CR62","doi-asserted-by":"publisher","first-page":"D833","DOI":"10.1093\/nar\/gkw943","volume":"45","author":"J Pinero","year":"2017","unstructured":"Pinero, J. et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 45, D833\u2013D839 (2017).","journal-title":"Nucleic Acids Res."}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-020-00376-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-020-00376-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-020-00376-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T11:14:12Z","timestamp":1670238852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-020-00376-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,8]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["376"],"URL":"https:\/\/doi.org\/10.1038\/s41420-020-00376-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-30473\/v1","asserted-by":"object"}]},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,8]]},"assertion":[{"value":"18 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None of the authors have any conflict of interests with respect to the current study. A.S. serves as a private consultant to develop biomarkers for a different immune-disorder related disease for a company.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"141"}}